ArticleGlobal heart2025
Burden of Hypertensive Heart Disease and Its Risk Factors in East Asia, 1990-2021: Findings From the Global Burden of Disease Study 2021.
Article in Global heart, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Chronic kidney disease due to hypertension in China, Japan, and the Republic of Korea: trends from the Global Burden of Disease Study 1990-2023.International urology and nephrology · 2026Article
- Valorization of Whey into a Bioactive Hydrolysate with ACE-Inhibitory Activity and Food Application Potential.Foods (Basel, Switzerland) · 2026Article
- Barriers and facilitators to the use of Hypercare APK app in hypertension management: a qualitative inquiry into highly educated participants' experiences in Ilorin, Nigeria.Frontiers in digital health · 2026Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Long-term hypertensive heart disease (HHD) trends in East Asia offer insights for heart disease prevention. We analyzed HHD burden trends in East Asia (1990-2021). Methods: We analyzed trends in age-standardized prevalence (ASPR), death, and disability-adjusted life-years (DALYs) rates of HHD in East Asia from 1990 to 2021 using data from the Global Burden of Disease Study 2021. Annual average percent changes (AAPC) were calculated via Joinpoint regression. Relative risks were estimated via population attributable fraction (PAF). Results: In 2021, East Asia reported 4,354,899 prevalent cases of HHD, 361,483 deaths and 6,079,780 DALYs. East Asia has seen a decrease in the overall prevalence of hypertensive heart disease (HHD) from 1990 to 2021, yet the ASPR for HHD has increased in the last decade, from 2012 to 2021. During this period, developed areas such as Japan have observed a growing trend of HHD among younger demographics. In contrast, developing regions like North Korea continue to face challenges in managing the condition effectively. The burden of HHD is particularly pronounced among females over 75 years of age, while males exhibit higher risk due to poor lifestyle factors. From 1990 to 2021, the PAF due to high body mass index (BMI) consistently increased across East Asia, with the following AAPC and 95% confidence interval (95% CI): China (1.55, 95%CI: 1.54, 1.56), Japan (0.79, 95%CI: 0.78-0.81), South Korea (0.86, 95%CI: 0.85, 0.86), China-Taiwan (1.3, 95%CI: 1.28, 1.33), North Korea (1.55, 95%CI:1.54, 1.55), and Mongolia (0.24, 95%CI: 0.23, 0.25). Conclusions: East Asia faces a significant HHD prevalence, with elderly females needing particular focus. High BMI is a notable risk factor. Given the differing HHD impacts across regions, targeted strategies that consider regional and national differences are essential for reducing the burden.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.